Suchergebnisse - "Flaherty, Kevin R"

PubPharm (20)

1

Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosis

enthalten in: The European respiratory journal | 2024

von Wijsenbeek, M. | Swigris, J. | Inoue, Y. | +8

CommentIn: Eur Respir J. 2024 Feb 1;63(2):. - PMID 38302183

2

Effect of Nintedanib in Patients with Progressive Pulmonary Fibrosis in Subgroups with Differing Baseline Characteristics

enthalten in: Advances in therapy | 2023

von Kolb, M. | Flaherty, K. | Silva, R. | +6

3

Nintedanib in children and adolescents with fibrosing interstitial lung diseases

enthalten in: The European respiratory journal | 2023

von Deterding, R. | Young, L. | DeBoer, E. | +12

CommentIn: Eur Respir J. 2023 Feb 2;61(2):. - PMID 36731900

4

Nintedanib in Patients With Autoimmune Disease-Related Progressive Fibrosing Interstitial Lung Diseases : Subgroup Analysis of the INBUILD Trial

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2022

von Matteson, E. | Kelly, C. | Distler, J. | +13

5

Nintedanib in progressive interstitial lung diseases : data from the whole INBUILD trial

enthalten in: The European respiratory journal | 2022

von Flaherty, K. | Wells, A. | Cottin, V. | +12

6

Effects of nintedanib by inclusion criteria for progression of interstitial lung disease

enthalten in: The European respiratory journal | 2022

von Maher, T. | Brown, K. | Kreuter, M. | +11

7

Systemic Sclerosis-Associated Interstitial Lung Disease : How to Incorporate Two Food and Drug Administration-Approved Therapies in Clinical Practice

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2022

von Khanna, D. | Lescoat, A. | Roofeh, D. | +6

CommentIn: Arthritis Rheumatol. 2022 Apr;74(4):733-734. - PMID 34612018

8

Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial : a randomised, double-blind, placebo-controlled, parallel-group trial

enthalten in: The Lancet. Respiratory medicine | 2020

von Wells, A. | Flaherty, K. | Brown, K. | +112

CommentIn: Lancet Respir Med. 2020 May;8(5):424-425. - PMID 32145831

9

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. Reply

enthalten in: The New England journal of medicine | 2020

von Flaherty, K. | Wells, A. | Brown, K.

CommentOn: N Engl J Med. 2020 Feb 20;382(8):779-780. - PMID 32074430

10

Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry

enthalten in: Respiratory research | 2020

von Holtze, C. | Freiheit, E. | Limb, S. | +5

CommentIn: Respir Res. 2020 May 6;21(1):105. - PMID 32375778